| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-143096 |
| P698 | PubMed publication ID | 25720407 |
| P50 | author | Tiziana Bacchetti | Q43264969 |
| P2093 | author name string | Leandro Provinciali | |
| Laura Mazzanti | |||
| Simona Luzzi | |||
| Alessia Giulietti | |||
| Arianna Vignini | |||
| Laura Nanetti | |||
| Gianna Ferretti | |||
| P2860 | cites work | Effect of N-homocysteinylation on physicochemical and cytotoxic properties of amyloid β-peptide | Q24300725 |
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Paraoxonase: a multifaceted biomolecule | Q30875090 | ||
| Oxidized LDL: diversity, patterns of recognition, and pathophysiology | Q33879138 | ||
| Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators | Q34268223 | ||
| Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease | Q34556739 | ||
| Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease | Q34747005 | ||
| An overview on the correlation of neurological disorders with cardiovascular disease | Q34800195 | ||
| Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase | Q35062409 | ||
| A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier | Q36267668 | ||
| Cardiovascular disease and Alzheimer's disease: common links | Q36570775 | ||
| Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1 | Q36615134 | ||
| Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study | Q36632984 | ||
| Oxidative stress and the pathogenesis of Alzheimer's disease | Q37101305 | ||
| Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease | Q37433250 | ||
| Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease | Q37463147 | ||
| The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease | Q37806707 | ||
| Peroxidation of lipoproteins in multiple sclerosis. | Q37941880 | ||
| Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis | Q38122527 | ||
| Molecular links between Alzheimer's disease and diabetes mellitus | Q38122603 | ||
| Paraoxonase 1 in neurological disorders. | Q38162323 | ||
| LOX-1 expression and oxidized LDL uptake and toxicity in the HN33 neuronal cell line | Q39007535 | ||
| Gene-environment interaction in Alzheimer's disease | Q39567162 | ||
| Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase | Q39802300 | ||
| The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux | Q40331033 | ||
| Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease | Q40384269 | ||
| What are lipoproteins doing in the brain? | Q40872027 | ||
| Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines | Q40951390 | ||
| Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6 | Q42450626 | ||
| Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor | Q42992999 | ||
| Serum nitrosative stress levels are increased in Alzheimer disease but not in vascular dementia | Q43053519 | ||
| The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy | Q43204113 | ||
| Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease | Q43604728 | ||
| Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity | Q44325183 | ||
| Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility | Q45138220 | ||
| Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity | Q45713440 | ||
| Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities | Q46401576 | ||
| Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs. | Q46473328 | ||
| Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma. | Q46974046 | ||
| Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine | Q48035160 | ||
| Expression and significance of plasma 3-NT and ox-LDL in patients with Alzheimer's disease. | Q50615307 | ||
| Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients. | Q50925350 | ||
| Beta-amyloid (Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation. | Q53289305 | ||
| Novel systemic markers for patients with Alzheimer disease? - a pilot study. | Q53296345 | ||
| Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease. | Q53299040 | ||
| Lipoprotein-associated phospholipase A2 is associated with risk of dementia | Q57781951 | ||
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 179-186 | |
| P577 | publication date | 2015-02-26 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1. | |
| P478 | volume | 46 |
| Q47926353 | A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease |
| Q49357611 | Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome |
| Q38950607 | Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases. |
| Q58574291 | Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development |
| Q37243907 | Higher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC Study |
| Q89347304 | Nutritional prevention of cognitive decline and dementia |
| Q89926815 | Uncovering pathophysiological changes in frontotemporal dementia using serum lipids |
Search more.